Publication | Open Access
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney
109
Citations
20
References
2012
Year
In patients with mRCC, AMG 386 plus sorafenib was tolerable but did not significantly improve PFS compared with placebo plus sorafenib.
| Year | Citations | |
|---|---|---|
Page 1
Page 1